Charlestown, MA, United States of America

Joshua P Frederick

This inventor holds 27 USPTO granted patents and 15 published patent applications and 3 EPO patents, primarily in mRNA Therapy. Top assignee: Modernatx, Inc.. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joshua P Frederick. Retrieved from https://idiyas.com/inventor/joshua-p-frederick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 15)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 140(Granted Patents)

Location History:

Boston, MA (US) (2018 - 2020)
Charlestown, MA (US) (2019 - 2023)
Cambridge, MA (US) (2023 - 2024)

Company Filing History:

27 out of 247

Modernatx, Inc.

patents

Years Active: 2018-2024

Loading Chart...

Areas of Expertise:

Polynucleotides

Interleukin-12

mRNA Therapy

Cancer Treatment

Immune Modulation

OX40 Ligand

Cellular Phenotypes

Combination Therapy

Polypeptides

Signal-Sensor

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11873327 - Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof (2024-01-16),

2. 11708396 - Signal-sensor polynucleotides for the alteration of cellular phenotypes (2023-07-25),

3. 11687256 - Methods of using OX40 ligand encoding polynucleotides (2023-06-27),

4. 11660341 - mRNA combination therapy for the treatment of cancer (2023-05-30),

5. 11596609 - Combinations of mRNAs encoding immune modulating polypeptides and uses thereof (2023-03-07),

6. 11571463 - Polynucleotides encoding interleukin-12 (IL12) and uses thereof (2023-02-07),

7. 11421011 - Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof (2022-08-23),

8. 11403008 - Methods of using OX40 ligand encoding polynucleotides (2022-08-02),

9. 11344504 - Combinations of mRNAs encoding immune modulating polypeptides and uses thereof (2022-05-31),

10. 11311602 - Polynucleotides encoding interleukin-12 (IL12) and uses thereof (2022-04-26),

11. 11185510 - Combinations of mRNAs encoding immune modulating polypeptides and uses thereof (2021-11-30),

12. 11071716 - Combinations of mRNAs encoding immune modulating polypeptides and uses thereof (2021-07-27),

13. 11003366 - Methods of using OX40 ligand encoding polynucleotides (2021-05-11),

14. 11000573 - Polynucleotides encoding interleukin-12 (IL12) and uses thereof (2021-05-11),

15. 10973917 - MRNA combination therapy for the treatment of cancer (2021-04-13),

Title: The Innovative Mind of Joshua P Frederick

Introduction: Joshua P Frederick is a renowned inventor based in Charlestown, MA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Joshua P Frederick holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics.

Career Highlights: With a career spanning over two decades, Joshua has been instrumental in developing cutting-edge solutions that have revolutionized industries. His work has been recognized globally for its ingenuity and impact.

Collaborations: Joshua P Frederick has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines has led to the creation of innovative products that have improved the lives of many.

Conclusion: Joshua P Frederick's passion for innovation and his relentless pursuit of excellence continue to drive him towards creating solutions that shape the future. His contributions to the world of inventions are truly remarkable.

Profile summary based on public USPTO records.